Skip to content
Search

Latest Stories

Lloyds and PDA agreed on pay settlement for store pharmacists

Lloyds Pharmacy has offered three per cent increase in base pay backdated to 1 April for its store pharmacists, the union of Pharmacists’ Defence Association (PDAU) who represented them has announced.

“We are pleased to announce that following a consultation of its members, the PDAU has informed the company that agreement can be reached on the company’s latest offer, made in July 2022,” said the PDAU.


The offer made by the company also includes introduction of an overtime rate of 1.5 times basic pay for each hour worked after contracted hours. This will run for a trial period and be reviewed as part of the next pay round.

“All pharmacists will receive an initial £1,000 payment under the proposed LTIP scheme, paid in April 2024. This will be to all in the bargaining unit and will not be dependent on meeting any criteria such as targets,” said PDAU.

“In addition, the company will introduce a Long-Term Incentive Plan which will see additional payments made to those paid under any existing bonus arrangements.”

Kevin Birch, chief retail officer at Lloyds Pharmacy, commented: “Our pharmacists are really important to us, and we are delighted to reach an agreement with them through our discussions with the PDAU. This is the first round of pay negotiations between Lloyds Pharmacy and the PDAU and we are pleased with how the process has worked and that we have ultimately reached a mutually agreeable outcome.

"This pay offer will see all eligible pharmacists receive an increase in their base pay, as well as overtime rates. We are also delighted to be introducing a market-leading long-term incentive plan that will give colleagues the opportunity to significantly enhance their earnings, by sharing in the success of the branch they are working in and their loyalty and tenure with Lloyds Pharmacy.”

Paul Moloney, PDAU national officer and lead negotiator, commented: “We welcome this agreement, the first of its kind between the PDAU and LloydsPharmacy and place on record our acknowledgement of the company’s efforts to work with us to achieve this agreement. Although falling short of the current inflation figures this nevertheless represents the highest increase many members will have seen in recent years.”

More For You

NICE approves AstraZeneca’s twice-a-day tablet ‘capivasertib’ for advanced breast cancer

HR-positive, HER2-negative advanced breast cancer is currently incurable, and treatment aims to slow progression and prolong life

Gettyimages

NICE approves twice-a-day tablet for advanced breast cancer

Every year, thousands of people with hormone receptor (HR)-positive HER2-negative breast cancer could benefit from a new twice-a-day tablet, now set to be funded immediately through the Cancer Drugs Fund.

The National Institute for Health and Care Excellence (NICE) has approved the use of capivasertib (also known as Truqap), in combination with fulvestrant, as an option for around 1,100 adults with HR-positive HER2-negative breast cancer that has certain genetic mutations and has spread.

Keep ReadingShow less
ABPI and government fast-track VPAG scheme review to address high medicine payment rates

The 2025 VPAG payment rate for newer medicines has been set at 22.9 per cent.

Photo credit: gettyimages

Review of 2024 VPAG scheme to be completed by June

The Association of the British Pharmaceutical Industry (ABPI) and the government have agreed to bring forward a planned review of the 2024 Voluntary Scheme for Branded Medicines Pricing, Access, and Growth (VPAG), originally scheduled for autumn 2025.

The review is expected to be completed in June 2025, aligning with the anticipated release of the government’s 10-year NHS Plan and the Life Sciences Sector Plan as part of the broader industry strategy this summer.

Keep ReadingShow less
AAH upgrades ordering portal, making procurement easier for pharmacies

AAH Cascade compares prices and availability across suppliers

AAH Warehouse

AAH upgrades ordering portal to improve product visibility

Leading pharmaceutical wholesaler AAH Pharmaceuticals Ltd has introduced new digital functionalities to AAH Cascade, its independently managed ordering portal, making procurement easier and more cost-effective for pharmacies.

AAH Cascade compares product prices and availability across multiple suppliers, eliminating the need for manual searches.

Keep ReadingShow less
Majority of Brits neglect consistent skincare routine,  survey finds

On average, Brits go to bed without washing their face twice a week.

Photo credit: gettyimages

Skincare: One in five Brits go to bed without washing their face daily, survey finds

Nearly two-thirds of Brits (60 per cent) neglect a consistent skincare routine,with almost one in five going to bed without washing their face daily, according to a new survey by consumer health company Kenvue.

The UK-wide survey of 2,000 people revealed that one-third of respondents (34 per cent) spend five minutes or less on their daily skincare routine. On average, Brits go to bed without washing their face twice a week.

Keep ReadingShow less
Risk of pharmacy closures remains despite record funding uplift

Community pharmacy sector remains in a fragile position as the funding gap is still significant, says CCA.

gettyimages

Pharmacy closures still a risk as funding deal fails to cover costs – warns CCA

The community pharmacy sector has secured the largest funding uplift across the NHS, yet concerns remain that it may not be enough to prevent further closures and service reductions.

Following a six-week consultation with Community Pharmacy England (CPE), the government has approved a £3.073 billion funding package for 2025/26, supplemented by an additional £215 million to support Pharmacy First and other Primary Care Recovery Plan services.

Keep ReadingShow less